Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 04, 2025 08:30 ET | Source: Exousia Bio, Inc.

Renowned Immunologist and Urological Surgeon Dr. Marvin Hausman Featured in New Exousia Bio, Inc. Interview

OTC:LMMY Dr. Marvin Hausman, an esteemed Immunologist and Board-Certified Urological Surgeon. With more than five decades of experience in drug research.
December 02, 2025 10:28 ET | Source: Exousia Bio, Inc.

LAMY Completes Strategic Acquisition of Cancer Therapy Innovator Exousia AI, Inc.

LAMY, to become Exousia Bio, Inc. (OTCPINK: LMMY) announced the completion of the acquisition of 100% of Exousia AI, Inc. in an all-stock transaction.
December 02, 2025 10:28 ET | Source: Exousia Bio, Inc.

LAMY Completes Strategic Acquisition of Cancer Therapy Innovator Exousia AI, Inc.

LAMY, to become Exousia Bio, Inc. (OTCPINK: LMMY) announced the completion of the acquisition of 100% of Exousia AI, Inc. in an all-stock transaction.